Yanni Xu

1.7k total citations
62 papers, 1.3k citations indexed

About

Yanni Xu is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Yanni Xu has authored 62 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 22 papers in Surgery and 19 papers in Oncology. Recurrent topics in Yanni Xu's work include Cholesterol and Lipid Metabolism (19 papers), Peroxisome Proliferator-Activated Receptors (16 papers) and Drug Transport and Resistance Mechanisms (12 papers). Yanni Xu is often cited by papers focused on Cholesterol and Lipid Metabolism (19 papers), Peroxisome Proliferator-Activated Receptors (16 papers) and Drug Transport and Resistance Mechanisms (12 papers). Yanni Xu collaborates with scholars based in China, United States and Australia. Yanni Xu's co-authors include Shuyi Si, Suowen Xu, Peter J. Little, Zheng Gen Jin, Zheng‐Gen Jin, Marina Koroleva, Shuya Zhang, Bin Hong, Yongzhen Li and Ni Li and has published in prestigious journals such as Analytical Chemistry, PLANT PHYSIOLOGY and Analytical Biochemistry.

In The Last Decade

Yanni Xu

59 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanni Xu China 18 650 229 203 181 146 62 1.3k
Yang Fu China 21 506 0.8× 216 0.9× 154 0.8× 141 0.8× 289 2.0× 61 1.1k
Xianlin Han China 17 497 0.8× 222 1.0× 113 0.6× 110 0.6× 190 1.3× 70 1.1k
Hongfeng Zhang China 22 535 0.8× 237 1.0× 230 1.1× 214 1.2× 342 2.3× 66 1.4k
Manish Jain India 26 501 0.8× 197 0.9× 365 1.8× 181 1.0× 109 0.7× 104 1.8k
Yong Ji China 19 828 1.3× 293 1.3× 245 1.2× 296 1.6× 147 1.0× 39 1.6k
Si Chen China 26 952 1.5× 145 0.6× 133 0.7× 215 1.2× 219 1.5× 83 2.0k
Zhipeng Su China 19 622 1.0× 117 0.5× 206 1.0× 250 1.4× 108 0.7× 76 1.3k
Seddik Hammad Egypt 19 395 0.6× 142 0.6× 160 0.8× 148 0.8× 251 1.7× 61 1.2k
A. Baas United States 10 869 1.3× 158 0.7× 226 1.1× 97 0.5× 125 0.9× 23 1.7k
Xiaojie Ma China 23 762 1.2× 199 0.9× 154 0.8× 190 1.0× 140 1.0× 68 1.5k

Countries citing papers authored by Yanni Xu

Since Specialization
Citations

This map shows the geographic impact of Yanni Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanni Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanni Xu more than expected).

Fields of papers citing papers by Yanni Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanni Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanni Xu. The network helps show where Yanni Xu may publish in the future.

Co-authorship network of co-authors of Yanni Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yanni Xu. A scholar is included among the top collaborators of Yanni Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanni Xu. Yanni Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Shasha, Yining Li, Ting Yu, et al.. (2025). Discovery of potent antiosteoporotic cyclic depsipeptides with an unusual nitrile hydroxy acid from Microascus croci. Bioorganic Chemistry. 155. 108133–108133. 2 indexed citations
2.
Li, Yuting, Yang Cheng, Yanni Xu, et al.. (2025). Photosynthetic acclimation of wheat (Triticum aestivum) to winter. PLANT PHYSIOLOGY. 199(1).
4.
Liu, Jing, Yanni Xu, Ying Han, et al.. (2024). Toxicity Study on Crude Alkaloid Extracts of Houttuyniae herba Based on Zebrafish and Mice. Molecules. 29(5). 1107–1107.
5.
Li, Shunwang, Jinque Luo, Huan Liu, et al.. (2024). ASGR1 Deficiency Inhibits Atherosclerosis in Western Diet–Fed ApoE −/− Mice by Regulating Lipoprotein Metabolism and Promoting Cholesterol Efflux. Arteriosclerosis Thrombosis and Vascular Biology. 44(12). 2428–2449. 9 indexed citations
6.
Luo, Jinque, Huan Liu, Yanni Xu, et al.. (2024). Hepatic Sirt6 activation abrogates acute liver failure. Cell Death and Disease. 15(4). 283–283. 7 indexed citations
7.
Wang, Weizhi, Tingting Feng, Peng Liu, et al.. (2024). Antirheumatic drug leflunomide attenuates atherosclerosis by regulating lipid metabolism and endothelial dysfunction via DHODH/AMPK signaling pathway. International Journal of Biological Sciences. 20(10). 3725–3741. 8 indexed citations
8.
Zhang, Yuyan, et al.. (2024). ASGR1 promotes atherosclerosis in western diet-fed ApoE-/- mice by increasing VLDL production and decreasing cholesterol efflux. Atherosclerosis. 395. 118429–118429. 1 indexed citations
9.
Cui, Mengyuan, Weizhi Wang, Jiaqi Zhang, et al.. (2023). Visualization of the Ferroptosis in Atherosclerotic Plaques with Nanoprobe Engineered by Macrophage Cell Membranes. Analytical Chemistry. 96(1). 281–291. 9 indexed citations
10.
Liu, Xiaodi, Qi Zhang, Yanni Xu, et al.. (2023). Nanoparticles (NPs)-mediated Siglec15 silencing and macrophage repolarization for enhanced cancer immunotherapy. Acta Pharmaceutica Sinica B. 13(12). 5048–5059. 8 indexed citations
11.
Zhou, Huimin, Cong Zhao, Rong‐Guang Shao, Yanni Xu, & Wuli Zhao. (2023). The functions and regulatory pathways of S100A8/A9 and its receptors in cancers. Frontiers in Pharmacology. 14. 1187741–1187741. 30 indexed citations
12.
Liu, Chao, Yining Li, Ren Sheng, et al.. (2021). Synthesis of N-methylpyridine-chlorofuranformamide analogs as novel OPG up-regulators and inhibitors of RANKL-induced osteoclastogenesis. Bioorganic Chemistry. 116. 105361–105361. 2 indexed citations
13.
Jia, Xiaojian, Yu Du, Yongzhen Li, et al.. (2019). Identification of Novel Compounds Enhancing SR-BI mRNA Stability through High-Throughput Screening. SLAS DISCOVERY. 25(4). 397–408. 3 indexed citations
14.
Feng, Tingting, Peng Liu, Jinque Luo, et al.. (2018). SIRT1 activator E1231 protects from experimental atherosclerosis and lowers plasma cholesterol and triglycerides by enhancing ABCA1 expression. Atherosclerosis. 274. 172–181. 25 indexed citations
15.
Ni, Li, Xiao Wang, Yanni Xu, et al.. (2017). Identification of a Novel Liver X Receptor Agonist that Regulates the Expression of Key Cholesterol Homeostasis Genes with Distinct Pharmacological Characteristics. Molecular Pharmacology. 91(4). 264–276. 32 indexed citations
16.
Li, Ni, Xiao Wang, Peng Liu, et al.. (2016). E17110 promotes reverse cholesterol transport with liver X receptor β agonist activity in vitro. Acta Pharmaceutica Sinica B. 6(3). 198–204. 12 indexed citations
17.
Chen, Minghua, Yanni Xu, Peng Liu, et al.. (2015). A new trichostatin analog fromStreptomycessp. CPCC 203909. Journal of Asian Natural Products Research. 17(6). 676–682. 6 indexed citations
18.
Chen, Minghua, Yi He, Yanni Xu, et al.. (2014). Identification of trichostatin derivatives from Streptomyces sp. CPCC 203909. Bioorganic & Medicinal Chemistry Letters. 25(3). 562–565. 13 indexed citations
19.
Bao, Yi, Li Wang, Yanni Xu, et al.. (2012). Salvianolic acid B inhibits macrophage uptake of modified low density lipoprotein (mLDL) in a scavenger receptor CD36-dependent manner. Atherosclerosis. 223(1). 152–159. 69 indexed citations
20.
Gao, Jie, Yanni Xu, Yuan Yang, et al.. (2008). Identification of Upregulators of Human ATP-Binding Cassette Transporter A1 via High-Throughput Screening of a Synthetic and Natural Compound Library. SLAS DISCOVERY. 13(7). 648–656. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026